z-logo
open-access-imgOpen Access
Comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.
Author(s) -
Kristina Dunder,
Pieter A. de Graeff,
E. Blind
Publication year - 2017
Publication title -
european heart journal - cardiovascular pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.895
H-Index - 26
eISSN - 2055-6845
pISSN - 2055-6837
DOI - 10.1093/ehjcvp/pvx006
Subject(s) - diabetes mellitus , risk assessment , risk aversion (psychology) , medicine , endocrinology , economics , management , financial economics , expected utility hypothesis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom